The SSI Mantra 3 has been put in in 75 hospitals world wide up to now. | Supply: SS Improvements Worldwide
SS Improvements Worldwide Inc. right this moment introduced that it has accomplished its first robotic cardiac surgical procedure within the Americas with its SSi Mantra 3 surgical robotic system.
On June 8, Dr. Juan Zuniga, a cardiothoracic surgeon at Interhospital in Guayaquil, Ecuador, grew to become the primary surgeon to carry out a robotic cardiac surgical procedure within the Americas and Western Hemisphere utilizing the SSi Mantra 3. The surgical procedure concerned a robotic Atrial Septal Defect closure. This process repairs a gap between the higher two chambers of the guts.
“On the heels of SSi Mantra’s debut in Latin American robotic surgical procedures, we determined to leverage this superior system in complicated specialties, notably in cardiovascular surgical procedures,” Dr. Zuniga stated.
“The expertise was good, this tools was very simple to deal with and manipulate, and the outcomes had been efficient as we did a transesophageal echocardiogram to confirm the whole closure of the communication between the 2 higher chambers of the guts,” he stated. “We had been very pleased with the ends in attaining a profitable closure, and the affected person is recovering very properly.”
SSi Mantra aids minimally invasive procedures
Interhospital is the primary hospital in South America to put in the SSi Mantra. It has carried out a wide range of complicated surgical procedures with the surgical robotic system since its set up.
“As a result of it’s a minimally invasive process, the restoration is way sooner, bleeding a lot much less, and since it’s finished robotically, the manipulation of the tissues is way more exact, and so is the suturing,” added Dr. Zuniga. “It provides the surgeon the arrogance that each sew that’s made with the platform is positioned exactly and with out complication.”
SS Improvements described the SSi Mantra as “a user-friendly, modular, multi-arm system.” Its know-how options embrace:
- Three to 5 modular robotic arms
- An open-faced ergonomic surgeon command heart
- A big 3D 4K monitor
- A contact panel monitor for all patient-related info shows
- A digital real-time picture of the robotic patient-side arm carts
- The flexibility to superimpose 3D fashions for diagnostic imaging
A imaginative and prescient cart supplies the table-side group with the identical magnified 3D 4K view because the surgeon to supply higher security and effectivity. The SSi Mantra makes use of greater than 40 kinds of robotic endo-surgical devices to assist totally different specialties, together with cardiac surgical procedure. The system has additionally been clinically validated in India, stated SS Improvements.
Now accepting session submissions!
SS Improvements surpasses 4,000 robotic surgical procedures
Final month, SS Improvements introduced that SSi Mantra has been utilized in 4,000 surgical procedures. These operations spanned greater than 100 several types of surgical procedures with none problems, accidents, or mortalities.
The Fort Lauderdale, Fla.-based firm famous this included roughly 215 cardiac surgical procedures. Six of those had been efficiently carried out through telesurgery throughout India with the SSi Mantra 3 surgical robotic system.
The Robotic Report beforehand mentioned SS Improvements’ telesurgery technique with Dr. Vishwa Srivastava, chief working officer and chairman of the board.
SS Improvements stated it has developed techniques to make robotic surgical procedure reasonably priced and accessible to a bigger section of the worldwide inhabitants. The corporate’s product vary consists of its proprietary SSi Mantra and its complete suite of SSi Mudra devices, which assist a wide range of surgical procedures.
The corporate launched its newest system, the SSi Mantra 3, in July 2024. The system obtained regulatory approval for distant surgical procedure and teleproctoring from the Central Medication Customary Management Group (CDSCO). This opens the door for distant surgical procedures and medical schooling.
In Might 2025, SS Improvements revealed plans to submit a de novo classification request to the U.S. Meals and Drug Administration for the system.
